Anti-Phospholipid Antibodies in Women with Placenta-Mediated Complications Delivered at >34 Weeks of Gestation

Objective: To determine the prevalence of positive antiphospholipid (aPL) antibodies among pregnant women with placenta-mediated complications delivered at >34(0/7) weeks of gestation. Methods: This was a single-center retrospective observational study conducted between 2017 and 2022. Inclusion c...

Descripción completa

Detalles Bibliográficos
Autores principales: Amikam, Uri, Hochberg, Alyssa, Shenhav, Michael, Haj, Lilian, Hochberg-Klein, Sarit, Hiersch, Liran, Yogev, Yariv
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342869/
https://www.ncbi.nlm.nih.gov/pubmed/37445549
http://dx.doi.org/10.3390/jcm12134516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342869/
https://www.ncbi.nlm.nih.gov/pubmed/37445549
http://dx.doi.org/10.3390/jcm12134516

Ejemplares similares